Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, November 9, 2023
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
Wed, November 8, 2023
[ Wed, Nov 08th 2023
] - WOPRAI
[ Wed, Nov 08th 2023
] - WOPRAI
[ Wed, Nov 08th 2023
] - WOPRAI
[ Wed, Nov 08th 2023
] - WOPRAI
[ Wed, Nov 08th 2023
] - WOPRAI
[ Wed, Nov 08th 2023
] - WOPRAI
[ Wed, Nov 08th 2023
] - WOPRAI
[ Wed, Nov 08th 2023
] - WOPRAI
[ Wed, Nov 08th 2023
] - WOPRAI
[ Wed, Nov 08th 2023
] - WOPRAI
[ Wed, Nov 08th 2023
] - WOPRAI
[ Wed, Nov 08th 2023
] - WOPRAI
[ Wed, Nov 08th 2023
] - WOPRAI
[ Wed, Nov 08th 2023
] - WOPRAI
[ Wed, Nov 08th 2023
] - WOPRAI
[ Wed, Nov 08th 2023
] - WOPRAI
[ Wed, Nov 08th 2023
] - WOPRAI
[ Wed, Nov 08th 2023
] - WOPRAI
[ Wed, Nov 08th 2023
] - WOPRAI
[ Wed, Nov 08th 2023
] - WOPRAI
[ Wed, Nov 08th 2023
] - WOPRAI
[ Wed, Nov 08th 2023
] - WOPRAI
Michael Ng Maintained (BLND) at Strong Buy with Increased Target to $1.6 on, Nov 8th, 2023
Michael Ng of Goldman Sachs, Maintained "Blend Labs, Inc." (BLND) at Strong Buy with Increased Target from $1.4 to $1.6 on, Nov 8th, 2023.
Michael has made no other calls on BLND in the last 4 months.
There are 2 other peers that have a rating on BLND. Out of the 2 peers that are also analyzing BLND, all agree with Michael's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Joseph Vafi of "Canaccord Genuity" Reiterated at Hold and Held Target at $2 on, Wednesday, September 27th, 2023
- Michael Turrin of "Wells Fargo" Maintained at Hold with Increased Target to $1.5 on, Thursday, August 10th, 2023
